77 results
8-K
MEIP
MEI Pharma Inc
18 Dec 23
Submission of Matters to a Vote of Security Holders
4:00pm
on Executive Compensation.
Proposal 3 was to approve, on an advisory basis, on the frequency of the approved, on an advisory basis … Years
Abstain
Broker Non-Votes
Based upon these results, the Board has determined that MEI Pharma will hold an advisory vote on executive compensation every
DEFC14A
Anson Funds Management LP
10 Oct 23
Proxy in contested solicitation
10:33am
EXECUTIVE COMPENSATION AND DIRECTOR COMPENSATION, INFORMATION CONCERNING THE COMMITTEES OF THE BOARD AND OTHER INFORMATION CONCERNING THE BOARD
PREC14A
p3o0h4i prin6hb19c
2 Oct 23
Preliminary proxy with contested solicitation
8:42am
DEFC14A
anc 9gdjh7it
26 Sep 23
Proxy in contested solicitation
3:42pm
PRRN14A
7pb7 rulx5ct
4 Aug 23
Revised preliminary proxy statement filed by non-management
5:15pm
PREC14A
lzmlysi
17 Jul 23
Preliminary proxy with contested solicitation
9:15am
425
a1vrs3dy3 jvnqcsak7
13 Jun 23
Business combination disclosure
4:10pm
8-K
EX-10.3
3hwug
13 Jun 23
MEI Pharma Announces Planned Departure of Chief Financial Officer Brian
4:01pm
424B3
hi1t1mwpok0swwj8b
6 Jun 23
Prospectus supplement
4:19pm
8-K
2j04veum1 1t
17 Dec 21
Amendments to Articles of Incorporation or Bylaws
4:45pm